Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NTM antisense RNA 2 (NTM-AS2)
- Target
- NTM-AS2
- Molecular classification
- Long non-coding RNA (lncRNA), Antisense RNA, Natural antisense transcript (NAT)
01
Overview
NTM antisense RNA 2 (NTM-AS2) appears to refer to an uncharacterized or incorrectly specified long non-coding antisense RNA transcript. The abbreviation "NTM" commonly refers to *non-tuberculous mycobacteria* in microbiology, not to an RNA or gene. General properties of **antisense RNAs** include binding complementary mRNA sequences and regulating gene expression at transcriptional or post-transcriptional levels, affecting processes such as epigenetic modification and gene silencing[1][5]. However, there is no evidence in the current biomedical literature or gene/protein databases for a specific antisense RNA called "NTM-AS2," suggesting a possible naming error, unpublished sequence, or database omission. It is not currently recognized as a therapeutic target, receptor, or druggable entity. If further clarification or a gene sequence is provided, it may help in identifying the transcript accurately.
- Other names
- NTM-AS2NTM antisense RNA 2
02
Biological functions
Regulation of gene expressionPossible involvement in epigenetic regulation
03
Disease associations
Other
Beyond the preview
Go deeper on NTM antisense RNA 2 (NTM-AS2).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NTM antisense RNA 2 (NTM-AS2).